Global challenges of implementing human papillomavirus vaccines
Open Access
- 1 January 2011
- journal article
- Published by Springer Science and Business Media LLC in International Journal for Equity in Health
- Vol. 10 (1), 27
- https://doi.org/10.1186/1475-9276-10-27
Abstract
Human Papillomavirus vaccines are widely hailed as a sweeping pharmaceutical innovation for the universal benefit of all women. The implementation of the vaccines, however, is far from universal or equitable. Socio-economically marginalized women in emerging and developing, and many advanced economies alike, suffer a disproportionately large burden of cervical cancer. Despite the marketing of Human Papillomavirus vaccines as the solution to cervical cancer, the market authorization (licensing) of the vaccines has not translated into universal equitable access. Vaccine implementation for vulnerable girls and women faces multiple barriers that include high vaccine costs, inadequate delivery infrastructure, and lack of community engagement to generate awareness about cervical cancer and early screening tools. For Human Papillomavirus vaccines to work as a public health solution, the quality-assured delivery of cheaper vaccines must be integrated with strengthened capacity for community-based health education and screening.Keywords
This publication has 109 references indexed in Scilit:
- Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiencyBMC International Health and Human Rights, 2010
- Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trialBMJ, 2010
- Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in IndiaNature Biotechnology, 2010
- Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005–2008)Social Science & Medicine, 2010
- Cervical cancer preventionCancer, 2010
- Portrait of a lengthy vaccination trajectory in Burkina Faso: from cultural acceptance of vaccines to actual immunizationBMC International Health and Human Rights, 2009
- Breast, cervical, and colorectal cancer screening rates amongst female Cambodian, Somali, and Vietnamese immigrants in the USAInternational Journal for Equity in Health, 2009
- Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio AppalachiaVaccine, 2009
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial resultsVaccine, 2008
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004